NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 948.60
+22.70 (2.45%)
Jan 7, 2026, 11:50 AM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 165.84 billion as of January 6, 2026. Its market cap has decreased by -35.96% in one year.
Market Cap
165.84B
Enterprise Value
136.45B
Revenue
43.90B
Ranking
n/a
PE Ratio
10.78
Stock Price
948.60
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 165.84B, an increase of 38,521.86%. That is a compound annual growth rate of 24.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 165.84B | 2.53% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |